Answers are grounded in this paper and cite their sources.
A peptidomimetic containing a thiazolo ring-fused 2-pyridone (C10) has now been reported to inhibit hypoxia-induced tolerance to isoniazid (INH) in Mycobacterium tuberculosis (Flentie et al., Proc. Natl. Acad. Sci. U. S. A., 2019). The C10 compound could also potentiate the bactericidal activity in aerobically grown bacilli, prevented selection of drug-resistant strains, and reversed INH resistance in katG (catalase-peroxidase) mutants.
No takes yet. Share an insight, caveat, or question.
Machado et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: